Real-world identification, staging, monitoring, management, and progression in patients with metabolic dysfunction-associated steatohepatitis (MASH) across the fibrosis spectrum in EU4+UK: A retrospective multi-country chart review on compensated MASH cirrhosis (MASH-MAP)